How Should Advisors Use Active ETFs?
Active ETF development continues to ramp up, but strategies often underperform their passive counterparts.

Sign up for market insights, wealth management practice essentials and industry updates.
Active can sometimes feel quite radioactive.
Active management is far from an esoteric corner of investing. It’s a popular product segment with massive amounts of development behind it, largely aimed at delivering strong returns. But the major problem is that it generally doesn’t outperform, especially over longer time horizons.
Just 25% of active strategies survived and beat their passive counterparts over the 10 years through this past June, according to Morningstar. For US large-cap ETFs, the success rate drops to just 17% outperforming the S&P 500 over the past decade, per S&P Global’s SPIVA Scorecard. As active ETF development ramps up, how should advisors approach these funds?
“You still have to be picky about the manager and their process,” said Dan Sotiroff, associate director of ETF and passive strategies at Morningstar. “The odds are very much stacked against them.” Advisors looking to add active strategies to satellite positions may have better luck with funds targeting small caps, foreign stocks, emerging markets and fixed income, he said.
See You at the Top
There are nearly 1,500 active ETFs in the US, excluding single-stock and leveraged funds, per data from Morningstar Direct. While not everyone uses the S&P 500 as a benchmark, roughly 450 are outperforming it this year.
The top 10 performers include funds targeting commodities, derivative income, healthcare, mid-cap value, emerging markets and foreign stocks:
- The Breakwave Tanker Shipping ETF (BWET) leads the pack, up 3,300% this year, due to the US-Iran War and restrictions in the Strait of Hormuz. When the conflict de-escalates, the fund could see a quick reversal.
- The Ark Genomic Revolution ETF (ARKG) ranks fifth, up about 39% year to date. While most holdings are positive, much of the fund’s outsized performance comes from a handful of stocks, including Twist Bioscience and 10X Genomics, both up more than 200%.
“You’ve got to be careful with thematic ETFs because they go through boom-bust periods and are volatile because they’re dependent on a very small number of stocks,” Sotiroff said. Cheaper funds tend to perform better, he said. “If you were to take the fees away and just look at gross returns, you tend to see active success rates go up a little bit, which just shows you that some of this is really just fees in the background.”
Pick and Choose: There needs to be a concerted vetting process when picking an active ETF. Rosalyn Kemp, founder of Chestnut Beach Wealth, looks for managers that screen for profitability and financial strength or weed out “zombie” companies that struggle to pay down debt or fund growth. “[They must have] a systematic process that improves on an index in a specific way,” she said. “A manager’s market forecast holds little appeal for me.”
Beating the market isn’t always the goal, either. Kemp also considers tax efficiency when evaluating active strategies. “A manager who is mindful of turnover and qualified dividends generates real value,” she said. “That’s a form of alpha that a pretax benchmark comparison will simply not capture.”











